A refined experimental model of metabolic dysfunction-associated steatohepatitis-driven liver cancer identifies macrophage Gadd45b as a central regulator of inflammation-driven tumor ...
A new Nature Metabolism study identifies the ubiquitin-conjugating enzyme UBE2N as the molecular switch that determines whether hepatocytes undergo protective ...
One of the world's most common chronic liver diseases may have a surprisingly precise weak point: a single pore in ...
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
In a groundbreaking study published in Nature Metabolism, researchers have unveiled a crucial mechanism underlying the sex-specific progression of metabolic ...
In recent years, the intersection of metabolic conditions and diabetes has garnered significant attention, particularly the implications of Metabolic Dysfunction-Associated ...
In a groundbreaking study set to redefine our understanding of liver fibrosis, researchers have uncovered a novel molecular pathway operating ...
In a groundbreaking development that could revolutionize the treatment of chronic liver diseases, researchers have identified a symbiotic filamentous fungus ...
Metabolic dysfunction-associated steatohepatitis (MASH) represents a complex and progressive liver disease, which often remains asymptomatic until advanced stages, posing considerable ...
Globally, the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has reached alarmingly high levels, with over 30% of the ...
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!
